Life Sciences
The pair talk about the shift from traditional clinical trials based on drug research to digital innovations.
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.
Symmetric Health Solutions CEO Rich Kucera and Northern Light's Matt Marston discuss how COVID-19 has affected the supply chain as well as Northern Light's successful vaccine rollout.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.
Along with the support of a Google Cloud-backed data platform, the partners will work to build and validate digital health programs for early intervention and engagement.
Moving from one-size-fits-all to personalized drug dosing can increase the efficacy and safety of medications, claims InsightRX CEO Sirj Goswami.
An initial pilot scheme will provide patients with access to local community pharmacists via the Push Doctor platform.
Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.
It's been quite a year for digital, from Akili's de novo clearance to the downfall of 'digital pill' maker Proteus. MobiHealthNews takes a look back at the highlights.